T-bet+ B cells: a common denominator in protective and autoreactive antibody responses?

A Myles, I Sanz, MP Cancro - Current opinion in immunology, 2019 - Elsevier
Highlights•T-bet+ B cells can be protective in infections and pathogenic in autoimmunity.•T-
bet+ B cells are antigen-experienced.•T-bet+ B cells may be plasmablast precursors or …

[HTML][HTML] The function of microRNAs in B-cell development, lymphoma, and their potential in clinical practice

B Zheng, Z Xi, R Liu, W Yin, Z Sui, B Ren… - Frontiers in …, 2018 - frontiersin.org
B-cell formation, development, and differentiation are complex processes regulated by
several mechanisms. Recently, there has been growing evidence indicating that microRNAs …

Getting specific: monoclonal antibodies in multiple sclerosis

A Lutterotti, R Martin - The Lancet Neurology, 2008 - thelancet.com
For more than a decade the only therapies that were available for multiple sclerosis (MS)
were two immunomodulatory drugs—interferon beta and glatiramer acetate—and the …

Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination

L Verkoczy, M Diaz - Current Opinion in HIV and AIDS, 2014 - journals.lww.com
It is increasingly apparent that immune tolerance, sometimes invoked by self-reactivity that
overlaps with bnAb epitope specificity, adds to a formidable set of roadblocks impeding …

Dual regulation of IRF4 function in T and B cells is required for the coordination of T–B cell interactions and the prevention of autoimmunity

PS Biswas, S Gupta, RA Stirzaker, V Kumar… - Journal of Experimental …, 2012 - rupress.org
Effective humoral responses to protein antigens require the precise execution of carefully
timed differentiation programs in both T and B cell compartments. Disturbances in this …

Dysregulation of T follicular helper cells in lupus

JD Mountz, HC Hsu… - The Journal of Immunology, 2019 - journals.aai.org
Although multiple and overlapping mechanisms are ultimately responsible for the
immunopathology observed in patients with systemic lupus erythematosus, autoreactive Abs …

Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from lupus

M Radic, I Neeli, T Marion - Expert Opinion on Biological Therapy, 2022 - Taylor & Francis
Introduction Medicine stands at the threshold of a new era heralded by the vast potential of
cell engineering. Like advances made possible by genetic engineering, current prospects …

The role of B cells in multiple sclerosis: Current and future therapies

A Negron, RR Robinson, O Stüve, TG Forsthuber - Cellular immunology, 2019 - Elsevier
While it was long held that T cells were the primary mediators of multiple sclerosis (MS)
pathogenesis, the beneficial effects observed in response to treatment with Rituximab (RTX) …

Association of defective regulation of autoreactive interleukin‐6–producing transitional B lymphocytes with disease in patients with systemic sclerosis

TE Taher, VH Ong, J Bystrom, S Hillion… - Arthritis & …, 2018 - Wiley Online Library
Objective Systemic sclerosis (SS c) has the highest case‐specific mortality of any rheumatic
disease, and no effective therapy is available. A clear manifestation of SS c is the presence …

Transitional B cells in quiescent SLE: an early checkpoint imprinted by IFN

Y Dieudonné, V Gies, A Guffroy, C Keime, AK Bird… - Journal of …, 2019 - Elsevier
Systemic lupus (SLE) is characterized by a break of B cell tolerance that plays a central role
in disease pathophysiology. An early checkpoint defect occurs at the transitional stage …